Abstract | BACKGROUND: METHODS: Experiments were performed with SK-N-SH and HS 68. Cell cultures were treated with NCP for 1, 3, and 5 min. NCP was applied using three different strategies: direct NCP application to cell cultures, to only media, and to only cells. Evaluation of cell viability and the level of the reactive oxygen species (ROS) was performed. N-acetyl-L-cysteine (NAC) was also used to antagonize intracellular ROS. Cleaved caspase 3, PARP, aquaporin (AQP) 3 and 8 were detected. RESULTS: NCP induced a gradual decrease in the SK-N-SH cell viability. In contrast, the viability of HS 68 cells did not change. SK-N-SH cells viability was reduced the most when the only media-NCP application strategy was employed. Intracellular ROS levels were significantly increased with time. Cleaved caspase 3 and PARP were increased at 6 h after NCP application. SK-N-SH cells remained viable with NAC after NCP application. AQP 3 and 8 were over-expressed in SK-N-SH cells. CONCLUSION: These findings demonstrate the anti- cancer effect of NCP on neuroblastoma cells. NCP enhanced the selective apoptosis of neuroblastoma cells due to the increased intracellular ROS.
|
Authors | Jung-Han Lee, M Shriya Jaiswal, Yoon-Seo Jang, Jeong-Hae Choi, Gyoo-Cheon Kim, Jin-Woo Hong, Dae-Seok Hwang |
Journal | BMC complementary medicine and therapies
(BMC Complement Med Ther)
Vol. 24
Issue 1
Pg. 46
(Jan 20 2024)
ISSN: 2662-7671 [Electronic] England |
PMID | 38245726
(Publication Type: Journal Article)
|
Copyright | © 2024. The Author(s). |
Chemical References |
- Reactive Oxygen Species
- Caspase 3
- Plasma Gases
- Ozone
- Poly(ADP-ribose) Polymerase Inhibitors
- Acetylcysteine
|
Topics |
- Humans
- Reactive Oxygen Species
(metabolism)
- Caspase 3
(metabolism)
- Plasma Gases
(pharmacology, therapeutic use)
- Ozone
(pharmacology, therapeutic use)
- Poly(ADP-ribose) Polymerase Inhibitors
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Apoptosis
- Neuroblastoma
(drug therapy, metabolism)
- Acetylcysteine
(pharmacology, therapeutic use)
|